![Ashleigh Barreto](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ashleigh Barreto is currently the Head of Investor Relations and Corporate Communications at Viracta Therapeutics, Inc. Prior to this, she worked as the Director of Communications and Investor Relations at Adamas Pharmaceuticals LLC and as the Head of Investor and Media Relations at XOMA Corp.
| Empresas | Cargo | Inicio |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Contacto de Relaciones con Inversores | 01/10/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| ADAMAS PHARMACEUTICALS, INC. | Contacto de Relaciones con Inversores | 01/12/2018 |
| XOMA ROYALTY CORPORATION | Contacto de Relaciones con Inversores | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 3 |
|---|---|
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Viracta Therapeutics, Inc.
 Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
